Sysmex Portugal

Sentimag® - Magtrace® in breast cancer

Mais detalhes

Many treatments for early-stage breast cancer involve sentinel lymph node biopsy (SLNB). This method, which identifies the lymph nodes with the highest potential for harbouring metastases, helps to determine the nodal stage of the cancer and make informed decisions for surgery and subsequent treatment.

Standard SLNB uses radioisotopes for sentinel node localisation. We offer an effective clinical solution that uses safe magnetic fields instead. This eliminates concerns related to issues of safety, workflow and availability associated with ionising radiation. Best practice SLNB is now possible everywhere, with no time restrictions.

Our system consists of the Sentimag® probe and the Magtrace® magnetic tracer. First, the tracer is injected into the interstitial tissue to provide a traceable signal. Next, using the Sentimag® probe, the sentinel lymph nodes are located to determine how far the cancer has spread.

Magtrace® – An effective clinical solution

  • Perform best practice SLNB in any clinical setting
  • Eliminate issues with radioactive materials; reach equivalent clinical outcomes
  • As a surgeon, organise and manage the SLNB procedure to suit your needs
  • Inject the tracer at the most convenient time, up to seven days in advance
  • No evidence of anaphylaxis with interstitial tracer injection
  • Sentimag® and Magtrace® are CE-approved for SLN localisation


Endomag®, Sentimag®, Magseed® and Sienna+® are registered European Union trademarks of Endomagnetics Ltd ·
Magtrace® is a registered trademark of Endomagnetics Ltd in the United Kingdom ·

Tem uma pergunta e gostaria de entrar em contacto com os nossos especialistas? Envie-nos um pedido de informação.

Sysmex Portugal, S.A.

Parque Empresarial – Fr.B.1.3

Estrada Ext. da Circunvalação, 10748

4460-280 Senhora da Hora, Matosinhos


+351 220909410

Explorar mais



Imunoensaio quantitativo em látex para a medição de Calprotectina.



Subtipagem molecular completa de doentes com cancro da mama

Osna em cancro da mama

Osna em cancro da mama

OSNA: diagnóstico molecular de precisão que proporciona valor preditivo e prognóstico

Copyright © Sysmex Europe SE. All rights reserved.